Nissenson Allen has filed 6 insider transactions across 2 companies since May 2023.
Most recent transaction: a grant/award of 50000 shares of ROCKWELL MEDICAL, INC. ($RMTI) on May 20, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2025 | ROCKWELL MEDICAL, INC. | $RMTI | Nissenson Allen | Director | A | Common Stock | 50000 | $0.00 | 142,597.0000 | 34,056,920 | 54.00% | 0.15% |
| May 19, 2025 | Elicio Therapeutics, Inc. | $ELTX | Nissenson Allen | Director | A | Stock Option (Right to Buy) | 7900 | $0.00 | 7,900.0000 | 15,953,524 | 9999.99% | 0.05% |
| Nov. 21, 2024 | Elicio Therapeutics, Inc. | $ELTX | Nissenson Allen | Director | A | Stock Option (Right to Buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| May 21, 2024 | ROCKWELL MEDICAL, INC. | $RMTI | Nissenson Allen | Director | A | Common Stock | 36111 | $0.00 | 92,597.0000 | 0 | 63.93% | 0.00% |
| Dec. 28, 2023 | Elicio Therapeutics, Inc. | $ELTX | Nissenson Allen | Not found | A | Stock Option (right to buy) | 4100 | $0.00 | 4,100.0000 | 0 | 9999.99% | 0.00% |
| May 23, 2023 | ROCKWELL MEDICAL, INC. | $RMTI | Nissenson Allen | Director | A | Common Stock | 24715 | $0.00 | 124,203.0000 | 0 | 24.84% | 0.00% |